PuriCore's endoscope disinfector
This article was originally published in Clinica
Executive Summary
PuriCore has received US FDA 510(k) market clearance for its Sterilox endoscopy high-level disinfectant system for use in reprocessing and disinfecting heat-sensitive medical instruments between patient procedures. The technology produces principally hypochlorous acid - an antimicrobial - from the electrolysis of a saline solution. Sterilox solutions are non-toxic and of no risk to patients, healthcare professionals, or the environment, claimed the company. "This is a big step in bringing Sterilox to the US endoscopy market, which is the largest in the world," said Greg Bosch, CEO of the Malvern, Pennsylvania firm, which anticipates installing its first US beta sites for Sterilox by the end of this year.